NEWS IN BRIEF: Adhoc update

NEWS IN BRIEF: Adhoc update

AIDS Treatment Update, Issue 58, October 1997
Edward King

The ADHOC trial has recruited eleven patients in the UK. Fifteen clinical centres have now started recruiting into the trial and another 18 centres are preparing to participate. The trial is about to start in Australia and other countries soon.

ADHOC is a multi-national trial to assess the role of the drug adefovir dipivoxil in preventing CMV disease and delaying the progression of HIV disease - particularly to increase survival. The drug has activity against both CMV and HIV. The aim is to recruit 2,000 individuals at any stage of HIV infection as long as they have never had CMV disease nor take CMV prophylaxis.

The original design of the trial specified that potential participants' most recent CD4 count should be less than 100 but the trial Coordinating Committee has just agreed to enrol people whose last count was less than 200 as long as it has previously been less than 50 at any time.

971001
ATU5806

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1997 - AIDS Treatment Update. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. NAM Publications 16a Clapham Common Southside, London, England SW4 7AB; TEL: 01-71-627-3200 (from outside the UK: +44-171-627-3200); FAX: 01-71-627-3101 (from outside the UK: +44=171-627-3101) info@nam.org.uk http://www.nam.org.uk

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1997. AEGIS.